Powered by

NeoImmuneTech, Genexine, SNUH and POSTECH researchers Announce Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019

Apr 03, 2019 - Business Wire

NeoImmuneTech, Inc. (NIT), a T cell-based therapeutics company, today announced the presentation of new research at the AACR Annual Meeting, being held March 29 - April 3, 2019 in Atlanta, GA. Study results regarding Hyleukin-7(TM) (Interleukin-7-hyFc), developed jointly with Korean affiliate company Genexine, Inc. (Genexine), will be presented in two posters.

Presentation Details:

Title: CT045. Hyleukin-7, a long-acting interleukin-7, increased absolute lymphocyte counts after subcu...